Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery
EAEsmée A. DijkstraPJPer J. NilssonGAGeke A.P. HospersRRRenu R. BahadoerEMElma Meershoek‐Klein Kranenbarg
University Medical Center Groningen · University of Groningen · +10 more institutions
Indexed incrossrefpubmed
Abstract
Objective
To analyze risk and patterns of locoregional failure (LRF) in patients of the RAPIDO trial at 5 years.
Background
Multimodality treatment improves local control in rectal cancer. Total neoadjuvant treatment (TNT) aims to improve systemic control while local control is maintained. At 3 years, LRF rate was comparable between TNT and chemoradiotherapy in the RAPIDO trial.
Citation impact
335
total citations
- FWCI
- 72.09
- Percentile
- 100%
- References
- 19
Citations per year
Authors
18- EAEsmée A. DijkstraCorresponding
University Medical Center Groningen, University of Groningen
- PJPer J. Nilsson
Karolinska University Hospital
- GAGeke A.P. HospersCorresponding
University Medical Center Groningen, University of Groningen
- RRRenu R. Bahadoer
Leiden University Medical Center
- EMElma Meershoek‐Klein Kranenbarg
Leiden University Medical Center
Topics & keywords
Topics
Keywords
- Medicine
- Radiation therapy
- Chemoradiotherapy
- Hazard ratio
- Chemotherapy
- Surgery
- Colorectal cancer
- Lymph node
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- SSanofi
- EExelixis
- SFSeerave Foundation
- AAAdvanced Accelerator Applications
- CCancerfondenAward: K2014-99X-22481-01-3
- MDMinisterio de Economía y Competitividad
- EEisai
- VVetenskapsrådetAwards: K2014-99X, K2014-99X-22481-01-3
- IIpsen
- SCSpanish Clinical Research NetworkAward: PT17/0017/0003
- IDInstituto de Salud Carlos IIIAwards: EC11-423, PT17/0017
- EREuropean Regional Development Fund